TECHMATRIX TO ACQUIRE MEDDOMAIN AS

Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.

This corporate disclosure from was processed by Pulse News Wire on February 17, 2026. It represents a primary source document for Japanese M&A sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.

TECHMATRIX TO ACQUIRE MEDDOMAIN AS SUBSIDIARY

Source disclosure: February 17, 2026 TECHMATRIX CORPORATION [3762.T] TOKYO, Feb 17 (Pulse News Wire) – TechMatrix Corporation (3762.T) and its subsidiary PSP Co., Ltd. signed a basic agreement to acquire MedDomain Inc., aiming to integrate advanced digital pathology technologies. Under the deal, TechMatrix and PSP plan to purchase shares worth approximately ¥2.300 billion to hold more than half of MedDomain's voting rights. The acquisition follows their initial capital and business